Yukako Ohyama
Overview
Explore the profile of Yukako Ohyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohyama Y, Yamaguchi H, Ogata S, Chiurlia S, Cox S, Kouri N, et al.
iScience
. 2022 Oct;
25(11):105223.
PMID: 36277451
Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the -glycosylation of the IgA1...
2.
Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, et al.
J Am Soc Nephrol
. 2022 Feb;
33(5):908-917.
PMID: 35115327
Background: IgA nephropathy (IgAN) primary glomerulonephritis is characterized by the deposition of circulating immune complexes composed of polymeric IgA1 molecules with altered O-glycans (Gd-IgA1) and anti-glycan antibodies in the kidney...
3.
Ohyama Y, Yamaguchi H, Nakajima K, Mizuno T, Fukamachi Y, Yokoi Y, et al.
Sci Rep
. 2021 Oct;
11(1):21209.
PMID: 34675329
No abstract available.
4.
Ohyama Y, Renfrow M, Novak J, Takahashi K
J Clin Med
. 2021 Aug;
10(16).
PMID: 34441764
IgA nephropathy (IgAN), the most common primary glomerular disease worldwide, is characterized by glomerular deposition of IgA1-containing immune complexes. The IgA1 hinge region (HR) has up to six clustered -glycans...
5.
Ohyama Y, Yazawa M, Haji Y, Ryuge A, Takizawa N, Nomura A, et al.
J Nephrol
. 2021 May;
35(2):687-688.
PMID: 34057674
No abstract available.
6.
Ohyama Y, Nakajima K, Renfrow M, Novak J, Takahashi K
Expert Rev Proteomics
. 2020 May;
17(4):275-296.
PMID: 32406805
Introduction: Protein glycosylation influences characteristics such as folding, stability, protein interactions, and solubility. Therefore, glycan moieties of therapeutic proteins and proteins that are likely associated with disease pathogenesis should be...
7.
Ohyama Y, Yamaguchi H, Nakajima K, Mizuno T, Fukamachi Y, Yokoi Y, et al.
Sci Rep
. 2020 Jan;
10(1):671.
PMID: 31959827
A common renal disease, immunoglobulin A (IgA) nephropathy (IgAN), is associated with glomerular deposition of IgA1-containing immune complexes. IgA1 hinge region (HR) has up to six clustered O-glycans consisting of...
8.
Ozeki T, Shimizu H, Fujita Y, Inaguma D, Maruyama S, Ohyama Y, et al.
Intern Med
. 2017 Mar;
56(5):481-485.
PMID: 28250291
Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant...
9.
Ryuge A, Shimizu H, Ohyama Y, Yamaguchi M, Nomura A, Maruyama S, et al.
Intern Med
. 2016 May;
55(9):1149-51.
PMID: 27150870
Diltiazem overdose has a high mortality rate due to cardiotoxicity associated with bradycardia and hypotension. A previous article reported that this type of overdose can cause acute tubular necrosis, which...
10.
Tomoda H, Tabata N, Ohyama Y, Omura S
J Antibiot (Tokyo)
. 2003 Apr;
56(1):24-9.
PMID: 12670046
Fungal roselipins, discovered as inhibitors of diacylglycerol acyltransferase (DGAT), consist of three parts; highly methylated C20 fatty acid, mannose and arabinitol. Demannosyl and/or dearabinitoyl roselipins were prepared chemically or enzymatically....